Sky Century Investment (SKYI) Cash from Operations (2012 - 2026)
Sky Century Investment's (SKYI) quarterly Cash from Operations came in at 59238.0 in Q2 2026, down 198.53% year-on-year from 60120.0 in Q2 2025, and down 2813.61% on a QoQ basis from 2183.0 in Q1 2026.
Sky Century Investment (SKYI) Cash from Operations (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 6 years of Cash from Operations data on file, last reported at 59238.0 in Q2 2026.
- On a quarterly basis, Cash from Operations fell 198.53% year-over-year to 59238.0 in Q2 2026; TTM through May 2026 was 56700.0, a 201.42% decrease from a year earlier, with the FY2025 full-year figure at 46481.0, up 9377.64% from the prior year.
- Cash from Operations for Q2 2026 stood at 59238.0, down from 2183.0 in the prior quarter.
- Over the last five years, Cash from Operations for SKYI reached as high as 60120.0 in Q2 2025 and fell as low as 59238.0 in Q2 2026.
- Historically, Cash from Operations has averaged 1728.5 across 3 years, with a median of 6051.5 in 2024.
- Across the five-year window, Cash from Operations jumped 1120.19% in 2025 and plunged 198.53% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 10827.0 in 2024, then jumped by 42.64% to 6210.0 in 2025, then slumped by 853.91% to 59238.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 59238.0 in Q2 2026, 2183.0 in Q1 2026, and 6210.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | -59,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -59,238.00 |
| May 31, 2026 | -59,238.00 |
| Feb 28, 2026 | 2,183.00 |
| Feb 28, 2026 | 2,183.00 |
| Nov 30, 2025 | -6,210.00 |
| Nov 30, 2025 | -6,210.00 |
| Aug 31, 2025 | 6,565.00 |
| Aug 31, 2025 | 6,565.00 |
| May 31, 2025 | 60,120.00 |
| May 31, 2025 | 60,120.00 |
| Feb 28, 2025 | -9,377.00 |
| Feb 28, 2025 | -9,377.00 |
| Nov 30, 2024 | -10,827.00 |
| Nov 30, 2024 | -10,827.00 |
| Aug 31, 2024 | 15,990.00 |
| Aug 31, 2024 | 15,990.00 |
| May 31, 2024 | -5,893.00 |
| May 31, 2024 | -5,893.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 29, 2024 | -10,598.00 |